My daughter saw this article on Yahoo and sent it on to me. Very interesting
since some of us have TM/MS I thought you might want to read it...
It's certainly an improvement over what's being going on with some of the
TM'ers on this list..... :)
Frank..... welcome back!! you certainly arrived with an agenda!!! Now read this
article tell us what you think and then have your martini...
There is always Hope! Trudy
– Researchers at the University of Cambridge said they have found that
alemtuzumab, a drug originally developed …
>
> LONDON (AFP) – Researchers at the University of Cambridge said Thursday they
> have found that a drug originally developed to treat leukaemia can halt and
> even reverse the debilitating effects of multiple sclerosis (MS).
>
> In trials, alemtuzumab reduced the number of attacks in sufferers and also
> helped them recover lost functions, apparently allowing damaged brain tissue
> to repair so that individuals were less disabled than at the start of the
> study.
>
> "The ability of an MS drug to promote brain repair is unprecedented," said Dr
> Alasdair Coles, a lecturer at Cambridge university's department of clinical
> neurosciences, who coordinated many aspects of the study.
>
> "We are witnessing a drug which, if given early enough, might effectively
> stop the advancement of the disease and also restore lost function by
> promoting repair of the damaged brain tissue."
>
> The MS Society, Britain's largest support charity for those affected by the
> condition, said it was "delighted" at the trial's results, which must be
> followed up with more research before the drug can be licensed.
>
> "This is the first drug that has shown the potential to halt and even reverse
> the debilitating effects of MS and this news will rightly bring hope to
> people living with the condition day in, day out," said head of research Lee
> Dunster.
>
> MS is an auto-immune disease that affects millions of people worldwide,
> including almost 100,000 in Britain and 400,000 in the United States.
>
> It is caused by the body's immune system attacking nerve fibres in the
> central nervous system, and can lead to loss of sight and mobility,
> depression, fatigue and cognitive problems. There is no cure, and few
> effective treatments.
>
> In the trial, 334 patients diagnosed with early-stage relapsing-remitting MS
> who had not previously been treated were given alemtuzumab or interferon
> beta-1a, one of the most effective licensed therapies for similar MS cases.
>
> After three years, alemtuzumab was found to reduce the number of attacks the
> patients suffered by 74 percent over the other treatment, and reduce the risk
> of sustained accumulation of disability by 71 percent over interferon beta-1a.
>
> Many individuals who took alemtuzumab also recovered some of their lost
> functions, becoming less disabled by the end, while the disabilities of the
> other patients worsened, the study in the New England Journal of Medicine
> said.
>
> Alastair Compston, professor of neurology and head of the clinical
> neurosciences department at Cambridge, said alemtuzumab was the "most
> promising" experimental drug for the treatment of MS.
>
> He expressed hope that further trials "will confirm that it can both
> stabilise and allow some recovery of what had previously been assumed to be
> irreversible disabilities".
>
> Alemtuzumab was developed in Cambridge and has been licensed for the
> treatment of chronic lymphocytic leukaemia.
>
>
_________________________________________________________________
You live life beyond your PC. So now Windows goes beyond your PC.
http://clk.atdmt.com/MRT/go/115298556/direct/01/
